View Article

Abstract

A simple rapid, accurate, precise, specific and economical spectrometric method for simultaneous estimation of Gliclazide (GLC) and Metformin hydrochloride (MET) is combined tablet dosage form has been developed. First method is based on an equation of area calculation of curve at two wavelength regions (228.6 to 224nm and 235 to 231 nm). Second method employs simultaneous equation at two wave length corresponding to 226.3 and 233.2 nm. Third method employs derivative spectroscopy at zero crossing points (226 and 232.9) in first order derivative spectra. Both the drugs obey Beer’s law in the concentration ranges employed for these methods.

Keywords

RP-HPLC method, Gliclazide, Metformin, Tablets.

Introduction

× Popup Image

Analytical chemistry:

Introduction to Pharmaceutical Analysis:

Analytical chemistry termed as science of determining the components of materials in terms of the elements or compound contained., Analytical techniques proved in assuring and maintain the quality of substance and are critical components of QA and QC. The analytical chemistry consists of,

  1. Qualitative analysis
  2. Quantitative analysis

Selection of analytical method:

  1. As accurate and precise as required.
  2. Most productive, economical and convenient.
  3. As simple as possible.

Classification of Analytical methods:

Analytical methods classified into two categories; Classical methods and instrumental methods: - 

  1. Classical methods

Classical methods of analysis is also known as wet chemical analysis. These methods use no mechanical or electronic instruments beyond a balance. They are traditionally used for both qualitative and quantitative analysis.

They are also divided into two sub-type :

  1. Volumetric method
  2. Gravimetric method

B) Instrumental methods

These methods are based upon the measurement of some physical properties as conductivity, electrodes potential, light absorption or emission, mass to change ratio and Fluroscence of substance. There are many techniques available for the analysis of analytes which can be broadly classified as,

    1. Spectroscopic techniques  
    2. Electrochemical techniques
    3. Chromatographic techniques
    4. Miscellaneous techniques
    5. Hyphenated techniques

Amongst all the techniques mentioned above UV-Visible spectrophotometry and High Performance Liquid Chromatography (HPLC) are the most widely used techniques for quantitative analysis of pharmaceutical substances. HPLC is most widely used of all the analytical techniques HPLC gives high sensitivity high resolution ready adaptability to accurate quantitative determinations and it is non-destructive and may be applied to thermally labile compounds (unlike GC); it is also very sensitive technique since it incorporates a wide choice of detection methods.

Figure: HPLC system

MATERIALS AND METHODS:

Materials and Reagents:

Procurement of Drug Samples:

Drug sample suppliers and Manufacturer

Sr. No.

Name of Drugs

Drug supplies & Manufacturer

1

Metformin HCL

INDOCO remedies Ltd, Mumbai, India.

2

Gliclazide

INDOCO remedies Ltd, Mumbai, India.

Reagents and chemicals:

Following reagents and chemicals were used in whole experimental procedures.

Reagents and chemicals used.

Name

Supplied by

Grade

Distilled water

In House

Double distilled

Methanol

Merck

HPLC

O-Phosphoric acid

Lobachemie

AR

Potassium dihydrogen phosphate

Analab Fine Chemicals

AR

Instrument Used:

List of apparatus/ instruments used

Sr. no.

Name

Model

Manufacturer/Supplier

1.

Weighing balance

PGB 100

Wenser High Precision Balance

2.

Digital PH Meter

PICO+

Lab India pvt ltd.

4.

Sonicator

WUC-4L

Capacity -4 liter

Wenser Ultra Sonicator

5.

Magnetic stirrer

 

Remi Equipment

6.

HPLC

HPLC 3000 Series

Analytical Technologies Ltd.

HPLC Instrument Information:

Parts of Instruments

Information

System

HPLC Binary Gradient System

Model no.

HPLC 3000 Series

Company

Analytical Technologies Ltd.

Pump

P-3000-M Reciprocating (40 MPa)

Column

Grace C18 (250mm×4.6ID, Partical size- 5 micron)

Detector

UV-3000-M

Software

HPLC Workstation

METHODS :

Solubility Studies: 

These studied was carried out with a view to find an ideal solvent in which drugs were completely soluble and stable. Various solvents were tried for checking solubility of Metformin HCL and Gliclazide. From solubility studies it was concluded that the drug is soluble in distilled water and methanol so these were selected as solvent for further analysis.

Selection of Analytical Wavelength:

A stock solution of drug was prepared in distilled water and UV spectrum of 100 μg/ml solutions of Metformin HCL and Glicazide was taken. For RP-HPLC analysis, spectra of drug were taken. Wavelength selected for analysis was such, that the drug, exhibited good absorbance.

HPLC Analysis

Optimization of HPLC method:

Initially different mobile phases used such as: 

Methanol: water in different proportions with adjustment of pH 6, 5.5 and 4.0 were tried. Then trials with methanol, acetonitrile and buffers were performed. Different concentrations of water with mixture of methanol and acetonitrile were tried in order to determine the best conditions for the effective separation of Metformin HCL and Gliclazide. The mobile phase consisting of Methanol; water pH 3 adjusted with ortho-phosphoric acid (80:20 % v/v) with 0.9 ml/min as flow rate was optimized as it was found to give best system suitability parameters.

Standard solutions:

An Accurately weighed quantity of about 10mg of Metformin HCL and   Gliclazide was taken in 100 ml volumetric flask dissolved in sufficient quantity of mobile phase, then sonicated for 15 min and diluted to 100ml with the same solvent so as to get the concentration of 10μg/ml. 1 ml of above solution transferred in 10 ml volumetric flask and the volume was made with diluents. The conc. of Drug is 10μg/ml.

Determination of λmax of Metformin HCL and Gliclazide

Standard stock solution of Metformin HCL and Gliclazide was diluted separately with diluents to obtain final concentration of 10μg/ml. solution was scanned using UV-Visible Spectrophotometer in the spectrum mode between the wavelength ranges of 400 nm to 200nm.

Validation of RP-HPLC:

  1. Specificity

Specificity studies were conducted to estimate the actual separation of analyte from placebo, and all other related peaks. The placebo solution usually consists of all excipients employed for dosage form manufacturing.

  1. System suitability

Two replicates of the sample and six replicates of standards were injected to verify the precision and accuracy of the chromatographic system. Different parameters of system suitability which include retention time, resolution, column theoretical plates, and tailing factor

  1. Linearity and Range:

Linearity of the method was studied by injecting six concentrations of the drug prepared in the mobile phase in the range of 10-50 μg/ml for MET and 10-50 μg/ml Gliclazide in triplicate into the RP- HPLC system keeping the injection volume constant. The peak areas were plotted against the corresponding concentrations to obtain the calibration curves. 

  1. Precision

Precision of the method was verified by repeatability studies. The repeatability of sample application and measurement of peak area for active compound were expressed in terms of RSD (relative standard deviation). Repeatability studies were performed by analyses of concentrations of 20,30,40 ug/ml Metformin and 20,30,40 ug/ml Gliclazide and  for RP-HPLC.  

  1. Limit of Detection (LOD) and Limit of Quantitation (LOQ):

The standard deviation of Y-intercept and slope of the calibration curves were used to calculate the LOD and LOQ for both the drugs using the following formulae.

LOD= 3.3(S)/s

LOQ = 10 (S)/ s

Where,

S =   Standard Deviation and

S =   Slope of the line

  1. Robustness:

To evaluate robustness of HPLC method, few parameters were deliberately varied. The parameters included variation of flow rate, percentage of buffer in the mobile phase and pH of mobile phase.

  1. Accuracy: 

Accuracy may often be expressed as percent recovery by the assay of a known amount of analyte added. The ICH documents recommend that accuracy should be assessed using a minimum of nine determinations over a minimum of three concentration levels, covering the specified range (i.e. three concentrations and three replicates of each concentration).

DRUG PROFILE

METFORMIN HCL:

I.

Chemical Proprties

Structure

 

 

CAS Registry No

1115-70-4

IUPAC Name

1-carbamimidamido-N-N-dimethylmethanimidamide

Mole. Formula

C4H11N5.HCL

Molecular Weight

165.63 g/mol.

II. Physical Properties:

Melting Point

222-2260C.

Appearance

White Crystaline  Powder

Solubility

Soluble             in         water,   methanol.

Insoluble chloroform, ether, acetone.

Pka

2.8 and 11.5 at 32 deg.

GLICLAZIDE

I. Chemical Proprties:

Structure

 

 

CAS Registry No

21187-98-4

IUPAC Name

pyrrol-2-(1H)-ylcarbamoyl)-4-N-(hexahydrocyclopenta(c) methyl) benzenesulphonamide

Mole. Formula

(C15H21N3O3S)

Molecular Weight

323.40g/mol

II. Physical Properties:

Melting Point

165-1690C

Appearance

White  powder

Solubility

Poorly soluble in water, and soluble in methanol, ethanol and  Acetonitrile

Pka

5.8

RESULT

The proposed simultaneous estimation method was found to be simple, precise, accurate and rapid for the determination of Metformin HCL and Gliclazide. The mobile phase is simple to prepare and economical. The sample recoveries in all the formulations were in good agreement with their respective label claim and their suggestive not interference of formulation excipients in the estimation. Hence this method can be conveniently adopted for routine analysis of Metformin HCL and Gliclazide in the pharmaceutical dosage form.

1.Metformin HCL

Sr.

No.

Parameters

Acceptance Criteria

Observation of Metformin HCL Method

1.

Specificity

RSD-NMT 2%

0.35

2.

System

suitability

RSD-NMT 2%

Retention time

Theoretical plate

Tailing factor

 

3.670 min

5997

1.20

3.

Precision

Repeatability Intraday precision Interday precision

 

RSD-NMT 2%

The % variance should NMT 1%

----------

 

0.035

0.07%

0.11%

 

4.

Linearity and Range

Correlation coefficient- NLT

0.999

Slope

0.999

 

82689

5.

Detection limit

Limit of Detection

0.39

6.

Limit of

Quantitation

Limit of Quantitation

1.18

7.

Accuracy

Mean sample recovered for three

sample prepared at different level

RSD- NMT 2%

%Recovery at

50% = 99.98

100%= 99.72

150%= 99.85

8.

Robustness

Critical parameters

Significant changed is observed at changed in flow rate & wavelength.

9.

Forced

Degradation

Remarkable degradation more than 20%

Remarkable degradation observed at alkaline & oxidation.

2.Gliclazide

Sr.

No.

Parameters

Acceptance Criteria

Observation of Gliclazide Method

1.

Specificity

RSD-NMT 2%

0.38

2.

System suitability

RSD-NMT 2%

Retention time

Theoretical plate

Tailing factor

 

6.541  min

12465

1.10

3.

Precision

Repeatability

Intraday precision

Interday precision

 

RSD-NMT 2%

The % variance should

NMT 1%

 

0.12

0.37%

0.36%

4.

Linearity and Range

Correlation coefficient- NLT 0.999

Slope

 

0.998

 

34643

5.

Detection limit

Limit of Detection

0.16

6.

Limit of Quantitation

Limit of Quantitation

0.49

7.

Accuracy

Mean sample recovered for three sample prepared

at different level RSD-

NMT 2%

%Recovery at

50% = 99.81

100%= 99.62

150%= 99.83

8.

Robustness

Critical parameters

Significant changed is observed at changed in temp.

9.

Forced Degradation

Remarkable degradation more than 20%

Remarkable degradation observed at alkaline & oxidation.

REFERENCES

  1. G. D Christian, Analytical Chemistry, John Wiley and sons, (2003), 1-3, 6thEdn, 604-620.
  2. D. A. Skoog, D.M. West, F.J. Holler. Analytical Chemistry an Introduction, Saunders College Publications, (2002), 3rd Edn,1-3.
  3. H.K. JAIN AND R.K AGRAWAL Simultaneous Estimation of Gliclazide and Metformin Hydrochloride in Combined Dosage Forms 
  4. British Pharmacopoeia, 16thEdn., Vol. I, H.M. Stationery Of- fice, London, 1998, 638.
  5. Indian Pharmacopoeia, 4thEdn., Vol. I, The Controller of Pub- lication, New Delhi, 1996, 469.
  6. Tanabe, S. and Kobayashi, K., Anal. Sci., 1987,3,69.
  7. Keal, J and Somogyi, A., J. Chromatogr. Biomed. Appl.
  8. Bari, R.V., Dhorda, U.J. and Sundaresan, M., Indian Drugs,1986, 51, 503.1999, 36, 459.
  9. Jain, H.K. and Agrawal, R.K., Indian Drugs, 2000, 37, 196. 
  10. Rondolph, L.K. and Ciminera, J.L., In; Gennaro, A.R., Eds; Remington Pharmaceutical Sciences, 17thEdn., Mack Pub- lishing Company, Easton, PA, 1985, 109.
  11. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P Rooyackers O, et al. Metformin increases AMP-activatedprotein kinase activity in skeletal muscle of subjects withType 2 diabetes. Diabetes 2007;2074:51.
  12. Rena G, Pearson E, Sakamoto K. Molecular mechanism of action of metformin old or new insights? Diabetologia 2013;56:1898-906.
  13. Defrenzo R. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999 281-303.
  14. Palmer KJ, Brogden RN. Gliclazide. Drugs 1993;46:92-125.
  15. Lee KY, Kim JR, Choi HC. Gliclazide, a KATP channel blocker,inhibits vascular smooth muscle cell proliferation through the CaMKKB-AMPK pathway Vase Pharmacol 2018
  16. Chhetri HP, Thapa P. Van Schepdael A Simple HPLC-UV method for the quantification of metformin in human plasma with one step protein precipitation. Saudi Pharmaceut J 2014,22-483-7.
  17. Kar M. Choudhury M. HPLC method for estimation of metformin hydrochloride in formulated microspheres and tablet dosage form. Indian J PharmaceutSci 2009 71:318-20.
  18. Talar R. Arshosaz J. Mostafavi A, Nokhodchi A. Development and validation of a novel rp-hplc method for Pharmacokinetic studies of giclazide in rat. FARMACIA 2011:59 388-95.
  19. Ghai D, Ganesh GL. HPLC method for determination of gliclazide in human serum, Asian J Chem 2009 21:4258-64.
  20. Neelima K, Prasad YR. Analytical method development and validation of metformin, voglibose, glimepiride in hulk and combined tablet dosage form by gradient rp-hplc. Pharmaceut Meth 2014;5:27-33.
  21. Lakshmi K. Rajesh T, Sharma S. Simultaneous determination of metformin and pioglitazone by reversed phase HPLC in pharmaceutical dosage forms. Int J Pharm PharmaceutSci 2009;1:162-6.
  22. Shirode A, Maduskar F, Deodhar M, Kadam V. Rp-HPLC and HPTLC methods for simultaneous estimation of metformin hydrochloride and vildagliptin from bulk and marketed formulation: development and validation. Br J Pharmaceut Res 2014;4:2370-86.
  23. Soni LK, Narsinghani T, Jain M. Development and validation of RP-HPLC method for simultaneous estimation of metformin hydrochloride and repaglinide in tablet dosage Form: J LiqChromatogrRelatTechnol 2012;35:385-92.
  24. Al Mahmud MA, Bhadra S, Haque A, Al Mamun ME, Haider 55. Development and validation of HPLC method for simultaneous determination of Gliclazide and Enalaprilmaleste in tablet dosage form. J PharmaceutSci 2015;13:51-6.
  25. Rathinavel C, Uma Nath U, Valarmathy J, Samueljoshua L, Thanuja CS, Ganesh M, et al. RP HPLC method for the simultaneous estimation of rosiglitazone and gliclazide in tablets. J Chem 2009;6:1188-92.
  26. Havele S, Dhaneshwar S. Development and validation of a HPLC method for the determination of metformin hydrochloride, gliclazide and piogliglitazone hydrochloride In multicomponent formulation. Webmedcentral 2010,1,WMC001078.
  27. Mansoory NM, Jain A. Simultaneous estimation of metformin hydrochloride, pioglitazone hydrochloride and ghclazide by validated rp-hple method in solid dosage form int J Pharm PharmaceutSci 2012,4.72-6.
  28. Ranetti M-C, Jonescu M, Hinescu L, lonica E, Anuta V Ranetti AE, et al. Validation of a HPLC method for the simultaneous analysis of metformin and gliclazide in human plasma. FARMACIA 2009;57:728-35.
  29. Rao B, Nikalje AP. Determination of gliclazide in a tablet dosage form in the presence of metformin hydrochloride by ion pair reversed phase liquid chromatographic technique AfrPharinPharmacol 2011;5:1331-7.
  30. AbuRuz S, Millership J, McElnay J. The development and validation of bquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or gumperide in plasma. J Chromatogr B 2005;817:277-86.
  31. Remedien Ltd. Mumbai; India.
  32. Rap lab. Analytical Research Centre. Nashik

Reference

  1. G. D Christian, Analytical Chemistry, John Wiley and sons, (2003), 1-3, 6thEdn, 604-620.
  2. D. A. Skoog, D.M. West, F.J. Holler. Analytical Chemistry an Introduction, Saunders College Publications, (2002), 3rd Edn,1-3.
  3. H.K. JAIN AND R.K AGRAWAL Simultaneous Estimation of Gliclazide and Metformin Hydrochloride in Combined Dosage Forms 
  4. British Pharmacopoeia, 16thEdn., Vol. I, H.M. Stationery Of- fice, London, 1998, 638.
  5. Indian Pharmacopoeia, 4thEdn., Vol. I, The Controller of Pub- lication, New Delhi, 1996, 469.
  6. Tanabe, S. and Kobayashi, K., Anal. Sci., 1987,3,69.
  7. Keal, J and Somogyi, A., J. Chromatogr. Biomed. Appl.
  8. Bari, R.V., Dhorda, U.J. and Sundaresan, M., Indian Drugs,1986, 51, 503.1999, 36, 459.
  9. Jain, H.K. and Agrawal, R.K., Indian Drugs, 2000, 37, 196. 
  10. Rondolph, L.K. and Ciminera, J.L., In; Gennaro, A.R., Eds; Remington Pharmaceutical Sciences, 17thEdn., Mack Pub- lishing Company, Easton, PA, 1985, 109.
  11. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P Rooyackers O, et al. Metformin increases AMP-activatedprotein kinase activity in skeletal muscle of subjects withType 2 diabetes. Diabetes 2007;2074:51.
  12. Rena G, Pearson E, Sakamoto K. Molecular mechanism of action of metformin old or new insights? Diabetologia 2013;56:1898-906.
  13. Defrenzo R. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999 281-303.
  14. Palmer KJ, Brogden RN. Gliclazide. Drugs 1993;46:92-125.
  15. Lee KY, Kim JR, Choi HC. Gliclazide, a KATP channel blocker,inhibits vascular smooth muscle cell proliferation through the CaMKKB-AMPK pathway Vase Pharmacol 2018
  16. Chhetri HP, Thapa P. Van Schepdael A Simple HPLC-UV method for the quantification of metformin in human plasma with one step protein precipitation. Saudi Pharmaceut J 2014,22-483-7.
  17. Kar M. Choudhury M. HPLC method for estimation of metformin hydrochloride in formulated microspheres and tablet dosage form. Indian J PharmaceutSci 2009 71:318-20.
  18. Talar R. Arshosaz J. Mostafavi A, Nokhodchi A. Development and validation of a novel rp-hplc method for Pharmacokinetic studies of giclazide in rat. FARMACIA 2011:59 388-95.
  19. Ghai D, Ganesh GL. HPLC method for determination of gliclazide in human serum, Asian J Chem 2009 21:4258-64.
  20. Neelima K, Prasad YR. Analytical method development and validation of metformin, voglibose, glimepiride in hulk and combined tablet dosage form by gradient rp-hplc. Pharmaceut Meth 2014;5:27-33.
  21. Lakshmi K. Rajesh T, Sharma S. Simultaneous determination of metformin and pioglitazone by reversed phase HPLC in pharmaceutical dosage forms. Int J Pharm PharmaceutSci 2009;1:162-6.
  22. Shirode A, Maduskar F, Deodhar M, Kadam V. Rp-HPLC and HPTLC methods for simultaneous estimation of metformin hydrochloride and vildagliptin from bulk and marketed formulation: development and validation. Br J Pharmaceut Res 2014;4:2370-86.
  23. Soni LK, Narsinghani T, Jain M. Development and validation of RP-HPLC method for simultaneous estimation of metformin hydrochloride and repaglinide in tablet dosage Form: J LiqChromatogrRelatTechnol 2012;35:385-92.
  24. Al Mahmud MA, Bhadra S, Haque A, Al Mamun ME, Haider 55. Development and validation of HPLC method for simultaneous determination of Gliclazide and Enalaprilmaleste in tablet dosage form. J PharmaceutSci 2015;13:51-6.
  25. Rathinavel C, Uma Nath U, Valarmathy J, Samueljoshua L, Thanuja CS, Ganesh M, et al. RP HPLC method for the simultaneous estimation of rosiglitazone and gliclazide in tablets. J Chem 2009;6:1188-92.
  26. Havele S, Dhaneshwar S. Development and validation of a HPLC method for the determination of metformin hydrochloride, gliclazide and piogliglitazone hydrochloride In multicomponent formulation. Webmedcentral 2010,1,WMC001078.
  27. Mansoory NM, Jain A. Simultaneous estimation of metformin hydrochloride, pioglitazone hydrochloride and ghclazide by validated rp-hple method in solid dosage form int J Pharm PharmaceutSci 2012,4.72-6.
  28. Ranetti M-C, Jonescu M, Hinescu L, lonica E, Anuta V Ranetti AE, et al. Validation of a HPLC method for the simultaneous analysis of metformin and gliclazide in human plasma. FARMACIA 2009;57:728-35.
  29. Rao B, Nikalje AP. Determination of gliclazide in a tablet dosage form in the presence of metformin hydrochloride by ion pair reversed phase liquid chromatographic technique AfrPharinPharmacol 2011;5:1331-7.
  30. AbuRuz S, Millership J, McElnay J. The development and validation of bquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or gumperide in plasma. J Chromatogr B 2005;817:277-86.
  31. Remedien Ltd. Mumbai; India.
  32. Rap lab. Analytical Research Centre. Nashik

Photo
Vaibhav Gadhave
Corresponding author

Matoshri Radha College of Pharmacy, Virgaon, Akole, Maharashtra, India

Photo
Kavita Patole
Co-author

Matoshri Radha College of Pharmacy, Virgaon, Akole, Maharashtra, India

Photo
Suvarna Khedkar
Co-author

Matoshri Radha College of Pharmacy, Virgaon, Akole, Maharashtra, India

Photo
Manasi Deshmukh
Co-author

Matoshri Radha College of Pharmacy, Virgaon, Akole, Maharashtra, India

Photo
Pallavi Phalke
Co-author

Matoshri Radha College of Pharmacy, Virgaon, Akole, Maharashtra, India

Kavita Patole, Suvarna Khedkar, Manasi Deshmukh, Vaibhav Gadhave, Pallavi Phalke, A Comprehensive Review on the Method Development and Analytical Estimation of Metformin and Gliclazide, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 5398-5406. https://doi.org/10.5281/zenodo.15757941

More related articles
Next Generation Incretin Therapies in Obesity: Evo...
Sonale S, Gowtham Arumugam , Revanth R...
A Review on Diuretic Activity, Pharmacological Use...
Mohd Sahil, Sudhir Kumar, Kamal Kishore...
Formulation and Evaluation of Polyherbal Shampoo...
Priyanka Bandichhode, Predeep Chabukswar, Shruti Narayankar, Kris...
Formulation and Evaluation of Natural Herbal Face Wash Tablets Containing Sandal...
Pradeep Chabukswar, Priyanka Bandichhode, Shivani Biskite, Deepak Bhosale...
A Research on Formulation and Evaluation of Herbal Soap...
Gurude Sneha, Shivraj Suryawanshi, Hambire Shradha, Gudde Saraswati, Ghevare Omkar, Gangapure Sakshi...
Virtual Screening of Bioactive Constituents of Lagenaria siceraria as Potential ...
Dinesh Kawade, Gun Chourasia, Shashwati Motghare, Dipak Rinait, Alpana Asnani...
More related articles
Formulation and Evaluation of Polyherbal Shampoo...
Priyanka Bandichhode, Predeep Chabukswar, Shruti Narayankar, Krishnamurthy Kamalapurkar...
Formulation and Evaluation of Polyherbal Shampoo...
Priyanka Bandichhode, Predeep Chabukswar, Shruti Narayankar, Krishnamurthy Kamalapurkar...